Walgreens Financial Statements and Financial Ratios Analyzed

Walgreens Financial Statements and Financial Ratios Analyzed

🚀 Explore Walgreens' 2022 Financial Health with Expert Guidance! 📊

Walgreens 2022 Beginner’s Guide Introduction:

Hello, future financial mavens! Ready to dissect the financial well-being of Walgreens in 2022? Step into "Walgreens 2022: Beginner's Guide to Financial Analysis," provided by Quality Business Consultant and penned by the financial guru, Paul Borosky, MBA. This guide isn't just about figures; it's your comprehensive pathway to understanding the fiscal dynamics of one of the leading players in the retail pharmacy sector!

Why You'll Love This Guide:

  • Navigated by a Finance Expert: 🎓 Delve into Walgreens' financials for 2022 with the insights from Paul Borosky, MBA, presented by Quality Business Consultant.
  • Summary Financial Statements: 📉 Get a look at Walgreens' income statements and balance sheets for 2022, so you can gain insights into its financial strategies and outcomes.
  • Extensive Financial Ratio Exploration: 🧮 Tackle over twenty vital financial ratios to assess Walgreens' fiscal performance and market position.
  • Demystifying Financial Terms: 📚 Our "In other words" sections translate financial jargon into clear, actionable insights.
  • Customized Analytical Techniques: 💡 Apply Paul's expert tips to enhance your ability to analyze financial data, invaluable for your academic and professional journey.
  • Detailed Insights with Comprehensive Report: 🔍 For a deeper dive, our "Financial Analysis & Report" offers an exhaustive look at Walgreens, combining AI insights with Paul Borosky's expert review.

Guide Highlights:

  • An approachable Legal Disclaimer
  • A motivating Forward to set the stage for your financial discovery
  • Thorough reviews of Income Statements and Balance Sheets for 2022
  • A deep dive into Financial Ratios to boost your analytical capabilities
  • A wealth of financial knowledge at your fingertips!

Table of Contents Sneak Peek:

  • Dissecting Income Statements: Analyzing revenue, expenses, and net earnings
  • Unpacking the Balance Sheet: Delving into assets, liabilities, and equity – the core pillars of financial health
  • Mastering Financial Ratios: Providing you with the tools to analyze Walgreens' financial standing

Who's This For?

Ideal for ambitious business students and emerging entrepreneurs, this guide is your key to mastering financial analysis, focusing on Walgreens.

Enhance Your Financial Acumen:

Advance your financial literacy with "Walgreens 2022: Beginner's Guide to Financial Analysis." Transform complex financial reports into a foundation for strategic decision-making.

Additional Note: This beginner's guide is designed to establish a solid grounding in essential financial principles, centering on income statements, balance sheets, and important financial ratios for their analysis. It offers a summarized snapshot of Walgreens' 2022 financials, providing specific data, calculations, and ratios to aid your analytical endeavors. While the guide equips you with the tools for financial exploration, the detailed analysis is yours to undertake. For those seeking an in-depth, company-specific financial overview, our "Financial Analysis & Report" provides thorough insights, blending AI accuracy with Paul Borosky, MBA's seasoned expertise.

Sincerely,

Paul, MBA.

PDF/Downloadable Version

Beginner's Guide to Walgreens 2022 Financial Analysis by Paul Borosky, MBA.

Click Below for the CURRENT

Downloadable PDF Price!!

Sample Financial Report

Sample Financial Report by Paul Borosky, MBA.
Financial Report Sample 2

Brief Summary: Walgreens Boots Alliance, INC. (WBA)

The Walgreens Boots Alliance Inc., or simply Walgreens (WBA), as their headquarters in Deerfield, Illinois.  The organization competes in the healthcare sector.  Specifically, the pharmaceutical retail industry.  At present, Walgreens employs about 230,000 individuals based on Yahoo finance provided information.

Financially speaking, the organization maintains a $35.1 billion market.  Yahoo Finance reports that Walgreens has a beta of .55.  This indicates that the company is less risky as compared to the overall market.  However, based on their slide in stock price, I would say the company is almost negatively correlated to the market.  In the last 52 weeks, Walgreens stock has fluctuated between $36.65 to $64.50.  The company does pay dividends.  Walgreens dividend yield the last 12 months was 4.64%.  The next dividend payout date is in August.

Walgreens Financial Report Sources

“Walgreens 2019 Company Analysis… For Beginners: Financial Statements and Financial Ratios: Defined, Discussed, and Analyzed for 5 Years” was written by, Paul Borosky, MBA. and owner of Quality Business Plan.  In this report, I used Walgreens 2018 10k, 2017 10k annual report, 2016 10k annual report, 2015 10k annual report, and 2019 10k annual report as the basis for information gathering. 

Section 1: Walgreens Income Statement Analyzed

In this section, I walk through a broad definition as to what an income statement is and why it is important.  From this, I then discuss and define income statement line items, such as revenues, gross profits, etc. in detail.  After each line item is defined and discussed, I finally offer a summary analysis of Walgreens important income statement line item trends from 2015 to 2019, in most cases.

Walgreens Inc. Revenue Growth.

Walgreens had revenues of approximately $103 billion in 2015.  The next two years, the company would moderately increase the revenues in the 2017 with about $118 billion.  However, in the last two years, ending in 2019, the firm would substantially increase the revenues ending 2019 with revenues of approximately $136.8 billion.  Surprisingly though, the organizations net profits have actually decreased as compared to the revenues.  This is more than a little bit concerning from an investor’s perspective.

Walgreens 2022 Summary Income Statement

Column1 2022 2021 2020 2019 2018
Revenues

                 132,703

                 132,509                  121,982                  120,074                    131,537
COGS

                 104,437

                 104,442                    95,905                    91,915

                   100,745

Gross Profit

                   28,265

                   28,067                    26,077                    28,159

                     30,792

 
SG&A                    27,295                    24,586                    25,436                    23,557                      24,694
Depreciation

                     1,990

                     1,973                      1,927                      2,038

                       1,770

R & D
Other
Total Operating Expenses

                   26,878

                   25,725                    25,095                    23,393

                     24,503

EBIT

                     1,387

                     2,342                         982                      4,766

                       6,289

Other Income
Interest Expense

                        400

                        905                         613                         650

                          616

EBT

                     3,985

                     1,995                         446                      4,359

                       5,975

Taxes

                         (30)

                        667                         339                         577

                          998

Net Income                     4,337                     2,542                        424                     3,962

                     5,031

Section 2: Walgreens Balance Sheet Analyzed

For Walgreens balance sheet, I again go through each important line item from the balance sheet.  In reviewing each line item, I will define their balance sheet line item, such as cash, property, plant and equipment, and liabilities between 2015 to 2019.  Next, I then offer a summary analysis of their important balance sheet line items.

Walgreens Inc. Cash.

Walgreens Inc. ended 2019 with approximately $3 billion with cash on hand.  In the next year, Walgreens would substantially increase their cash position and in 2016 with about $9.8 billion in the bank.  However, the organization would then continually drop in their cash position ending 2019 with $1 billion in the bank.  The substantial reduction in cash may be due to an acquisition.  Also, the company may have taken out significant debt in 2016, which drove up their cash position.

Walgreens 2022 Summary Balance Sheet

Column1 2022 2021 2020 2019 2018
Cash                        1,358                       559                       469                    1,023                       785
Short Term Investment                        1,114                       634
Account Receivable                        5,017                    5,663                    4,110                    7,226                    6,573
Inventory                        8,353                    8,159                    7,917                    9,333                    9,565
Other
Current Assets                    16,902                15,814                18,073                18,700                17,846
Net PPE                      11,729                  12,247                  12,796                  13,478                  13,911
Goodwill                      22,280                  12,421                  12,013                  16,560                  16,914
Other
Total Assets                    90,124                81,285                87,174                67,598                68,124
Accounts Payable                      11,255                  11,136                  10,145                  14,341                  13,566
Accrued Expense                        7,899                    7,260                    5,861                    5,474                    5,862
Accrued Taxes                             84                         94                         95                       216                       273
Notes Payable                        1,059                    1,305                       325                    5,738                    1,966
LT Debt - Current
Other
Total Current Liabilities                      22,583                  22,054                  27,070                  25,769                  21,667
LT Debt                      10,615                    7,675                  12,203                  11,098                  12,431
Other
Total Liabilities                    59,717                57,145                66,038                43,446                41,435
Common Stock                      10,950                  11,000                  10,773                  10,651                  10,505
Treasury                      20,683                  20,593                  20,575                  19,057                  15,047
Retained Earnings                      37,801                  35,121                  34,210                  35,815                  33,551
Other
Total Equity                    29,366                23,822                21,136                24,152                26,689
Total Equity & Liability                    90,124                81,285                87,174                67,598                68,124

Section 3: Walgreens Financial Ratios Analyzed

For this section, I have chosen several different financial ratios to review for Walgreens from 2015 to 2019.  In reviewing each of their financial ratios, I first start with defining the financial ratio.  Next, I supply the financial formula for calculating the specific ratio.  Finally, I offer a brief analysis of their important Financial ratios. 

Walgreens Inc. Current Ratio.

In 2015, Walgreens had a current ratio of approximately 1.19.  Because the company does deal with retail, the organization should employ a lower current ratio as compared to other industries.  For example, Walmart continuously has a current ratio well below 1.0.  This is because these types of organizations continually generate cash on a daily basis.  This enables the firm to optimize its current assets at a higher rate as compared to other industries.  In my most humble of opinion, Walgreens needs to employ similar strategies as compared to other retail industry competitors.

Walgreens Inc. Total Asset Turnover.

Walgreen's total asset turnover ended 2015 at 1.50.  In the next four years, Walgreens will continually improve their total asset turnover ending 2019 with 2.02.  This indicates that Walgreens management teams are taking steps to continually increase their total asset utilization.  Also, the firm may be liquidating underperforming assets to help improve this ratio on a continuous basis.

Walgreens Inc. Return on Assets.

Walgreen's return on assets ended 2015 at 6.22%.  In the next four years, Walgreens would fluctuate between 7.39% in 2018 to 5.77% in 2016.  The significant fluctuation of return on assets shows that the organization does not have a coherent strategy to continually improve and optimize the usage of assets from the perspective of revenue generation.  To improve on this ratio, the organization may wish to close down underperforming stores or take action to improve inventory holding practices.

Walgreens Inc. Debt ratio.

Walgreens ended 2015 with the debt ratio of 19.36%.  In the next year, the organization’s debt would climb to 25.73%.  Fortunately though, the last three years, Walgreens has taken significant steps to reduce their current debt ratio.  The steps resulted in a debt ratio of 16.42% in 2019.  In my opinion, this debt ratio may be an optimal level for the organization.  Going any lower may jeopardize the company’s ability to exploit right off opportunities for interest payments.  Also, additional funds that may be paid to paying down the debt could be used for expansion purposes.